Mona Alfaraj: Advancing Care in Inherited Platelet Disorders at 2nd International Hematology and Hemostasis Conference
Mona Alfaraj, Consultant Hematopathologist and Transfusionist, shared a post on LinkedIn:
“Being a member of the scientific committee at the 2nd International Hematology and Hemostasis Conference is an experience that carries a deep sense of honor, responsibility, and intellectual excitement.
It reflects not only recognition of one’s professional journey but also an opportunity to actively shape the scientific dialogue within a specialized and rapidly evolving field.
As a speaker, presenting on inherited macrothrombocytopenia brings a unique sense of purpose.
This group of rare heterogeneous platelet disorders, often underdiagnosed or misinterpreted, represents a critical intersection between clinical hematology and diagnostic hematology with genetic medicine.
Sharing insights on their pathophysiology, underlying genetic defects, diagnostic challenges, laboratory tools, and appropriate family management plan with avoiding mistreatment feels like contributing to a broader effort to improve patient’s experience outcomes and highlights the importance of genetic/molecular studies endpoint in the hemostasis pathway.
There is also a certain anticipation in engaging with local, regional and international experts – knowing that the discussion may spark new ideas, collaborations, or even challenge existing.
Ultimately, participating in this dual capacity transforms the conference from a passive event into an active, meaningful journey – one where knowledge is not only shared but also shaped, and where professional growth is intertwined with advancing patient care.
Here, from Inherited blood disorders center in Prince Mohammed Bin Fahd Hospital and Qatif Healthcare network, under supervision of E1Health cluster and with a great support from the leaders, we are shaping the future of hematology.
It was really a pleasure to be among welcoming and scientific team for this international event and it is always a pleasure to work with such team that gives a great example of a collaborative teamwork model in the health care services.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology